Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2014 - 2026)

Sarepta Therapeutics' Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $38.9 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 4.59% year-over-year to $38.9 million; the TTM figure through Mar 2026 stood at $294.0 million (down 81.22% YoY), while the FY2025 annual figure was $295.9 million, down 85.22% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $38.9 million, down from $99.9 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $965.1 million in Q4 2024, with the low at $38.9 million in Q1 2026.
• The 5-year median for Change in Acquisitions & Divestments is $348.7 million (2022), against an average of $320.5 million.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments jumped 1231.9% in 2022, then plunged 91.47% in 2025.
• Sarepta Therapeutics' Change in Acquisitions & Divestments stood at $446.5 million in 2022, then grew by 18.3% to $528.2 million in 2023, then jumped by 82.71% to $965.1 million in 2024, then tumbled by 89.65% to $99.9 million in 2025, then sank by 61.09% to $38.9 million in 2026.
• Business Quant data shows SRPT's Change in Acquisitions & Divestments at $38.9 million in Q1 2026, $99.9 million in Q4 2025, and $86.6 million in Q3 2025.